NCT00498368: Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy |
|
|
| Completed | 4 | 34 | US | Intravenous Rituximab, Rituxan, ACE/ARB, Angiotensin II blockade, Omega-3 Fatty Acid Fish Oil Supplement | Mayo Clinic, Ohio State University, Stanford University, University of North Carolina, Chapel Hill, Columbia University, Genentech, Inc., Biogen | IgA Nephropathy | 09/15 | 09/15 | | |
